SCHEMBL21156563

SCHEMBL21156563

C=C(c1c(C)c(C(=O)OC(C)C)cc2cc(-c3cc(OC)cc(OC)c3)cn12)N1CCOCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
EZH2 Q15910 2/20 0.34
EED O75530 1/20 0.34
RBBP4 Q09028 1/20 0.34
SUZ12 Q15022 1/20 0.34
AEBP2 Q6ZN18 1/20 0.34
POLB P06746 1/20 0.33
FKBP1A P62942 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
RAB9A P51151 2/20 0.32
KDM4E B2RXH2 2/20 0.32
NPC1 O15118 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21113204 0.92 RAB9A (0.42) ALDH1A1LMNASMN1; SMN2POLBFKBP1A
SCHEMBL21113144 0.91 RAB9A (0.42) ALDH1A1SMN1; SMN2L3MBTL1RAB9AKDM4E
SCHEMBL21157287 0.89 TSHR (0.41) SMN1; SMN2EZH2EEDRBBP4SUZ12
SCHEMBL21157283 0.87 ALOX15 (0.41) ALDH1A1LMNASMN1; SMN2POLBRAB9A
SCHEMBL19964426 0.87 NPC1 (0.41) ALDH1A1LMNASMN1; SMN2KDM4ENPC1
SCHEMBL21157293 0.86 ALDH1A1 (0.39) ALDH1A1LMNASMN1; SMN2EZH2EED
SCHEMBL21156593 0.86 EZH2 (0.38) ALDH1A1LMNASMN1; SMN2EZH2EED
SCHEMBL21157346 0.86 EZH2 (0.44) ALDH1A1LMNASMN1; SMN2EZH2EED
SCHEMBL21157370 0.86 EZH2 (0.48) ALDH1A1LMNASMN1; SMN2EZH2EED
SCHEMBL21157291 0.85 EED (0.43) ALDH1A1LMNASMN1; SMN2EZH2EED

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HAIHE BIOPHARMA CO. LTD. (CN) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof EZH2, IKZF2, SUZ12 ALDH1A1 2816/4885LMNA 2826/4885SMN1; SMN2 4308/4885
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF EZH2, IKZF2, SUZ12 ALDH1A1 2816/4885LMNA 2826/4885SMN1; SMN2 4308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.